Sonnet Biotherapeutics logo

Sonnet Biotherapeutics Share Price (NASDAQ: SONN)

$3.65

0.18

(5.19%)

Live

Last updated on

Check the interactive Sonnet Biotherapeutics Stock chart to analyse performance

Sonnet Biotherapeutics stock performance

as on August 26, 2025 at 12:40 AM IST

  • Today's Low:$3.50
    Today's High:$3.87

    Day's Volatility :9.56%

  • 52 Weeks Low:$1.08
    52 Weeks High:$19.30

    52 Weeks Volatility :94.4%

Sonnet Biotherapeutics Stock Returns

PeriodSonnet Biotherapeutics Holdings IncIndex (Russel 2000)
3 Months
191.6%
0.0%
6 Months
129.8%
0.0%
1 Year
-43.63%
0.0%
3 Years
-99.36%
-10.0%

Sonnet Biotherapeutics Holdings Inc Key Stats

Check Sonnet Biotherapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.47
Open
$3.3
Today's High
$3.87
Today's Low
$3.5
Market Capitalization
$23.4M
Today's Volume
$274.5K
52 Week High
$19.3
52 Week Low
$1.08
Revenue TTM
$1000.0K
EBITDA
$-14.0M
Earnings Per Share (EPS)
$-6.82
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-714.97%

Stock Returns calculator for Sonnet Biotherapeutics Stock including INR - Dollar returns

The Sonnet Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Sonnet Biotherapeutics investment value today

Current value as on today

₹63,588

Returns

₹36,412

(-36.41%)

Returns from Sonnet Biotherapeutics Stock

₹40,747 (-40.75%)

Dollar Returns*

₹4,335 (+4.33%)

Indian investors sentiment towards Sonnet Biotherapeutics Stock

-83.67%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Investment in Sonnet Biotherapeutics Shares from India has dropped by -83.67% over the past 30 days, indicating reduced transactional activity.

-75%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Search interest for Sonnet Biotherapeutics Stock from India on INDmoney has decreased by -75% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Sonnet Biotherapeutics Holdings Inc

  • Name

    Holdings %

  • Mmcap International Inc. Spc

    2.13%

  • Geode Capital Management, LLC

    0.40%

  • XTX Topco Ltd

    0.22%

  • Tower Research Capital LLC

    0.02%

Analyst Recommendation on Sonnet Biotherapeutics Stock

Rating
Trend

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Sonnet Biotherapeutics(by analysts ranked 0 to 5 stars)

Sonnet Biotherapeutics Share Price Target

What analysts predicted

Upside of 447.95%

Target:

$20.00

Current:

$3.65

Sonnet Biotherapeutics share price target is $20.00, a slight Upside of 447.95% compared to current price of $3.65 as per analysts' prediction.

Sonnet Biotherapeutics Stock Insights

  • Price Movement

    In the last 3 months, SONN stock has moved up by 207.1%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 18.62K → 1.0M (in $), with an average increase of 85.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -3.12M → -3.77M (in $), with an average decrease of 6.5% per quarter
  • SONN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.7% return, outperforming this stock by 108.9%
  • SONN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.4% return, outperforming this stock by 211.8%
  • Price to Sales

    ForSONN every $1 of sales, investors are willing to pay $9.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.9 for every $1 of sales.

Sonnet Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Sonnet Biotherapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Sonnet Biotherapeutics Holdings Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Sonnet Biotherapeutics Holdings Inc logo
-14.32%
129.8%
-43.63%
-99.36%
-99.95%
Regeneron Pharmaceuticals, Inc. logo
5.52%
-17.35%
-50.85%
-1.12%
-3.68%
Beone Medicines Ltd logo
6.51%
21.35%
57.45%
73.21%
25.84%
Vertex Pharmaceuticals Incorporated logo
-14.26%
-17.97%
-18.13%
40.27%
45.64%
Alnylam Pharmaceuticals, Inc. logo
39.9%
82.53%
68.83%
115.41%
241.51%

About Sonnet Biotherapeutics Holdings Inc

Sonnet BioTherapeutics Holdings, Inc., a biotechnology company, owns a platform for biologic medicines of single or bifunctional action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead product candidate is SON-1010, a fully human single-chain version of interleukin 12 for the treatment of solid tumor indications, including ovarian cancer, non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 to treat chemotherapy-induced peripheral neuropathy (CIPN), and diabetic peripheral neuropathy; SON-1210, a bispecific compound for solid tumor indications, including colorectal cancer; SON-1411, a bifunctional combination of human interleukin 18 (IL-18) inhibitor binding protein and single-chain human IL-12 (IL-12) for solid tumor cancers; and SON-1400, a monofunctional fusion protein comprising the IL-18 binding protein resistant domain linked to the FHAB. It has a license agreement with New Life Therapeutics Pte, Ltd. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin-6; and strategic development collaboration with Sarcoma Oncology Center to advance SON-1210. The company is headquartered in Princeton, New Jersey.
Organization
Sonnet Biotherapeutics
Employees
13
CEO
Mr. Raghu Rao
Industry
Consumer Services

Key Management of Sonnet Biotherapeutics Holdings Inc

NameTitle
Mr. Raghu Rao
Interim CEO & Director
Dr. John K. Cini Ph.D.
Chief Scientific Officer & Co-Founder
Mr. Donald J. Griffith CPA, CPA
CFO, Financial Controller & Director
Dr. Stephen J. McAndrew Ph.D.
President & Chief Business Officer
Dr. Gael Hedou Ph.D.
Chief Operating Officer
Ms. Susan Dexter
Chief Technical Officer
Dr. Richard T. Kenney FACP, M.D.
Chief Medical Officer
Mr. Manuel Dafonseca
Head of Clinical Operations

Important FAQs about investing in SONN Stock from India :

What is Sonnet Biotherapeutics share price today?

Sonnet Biotherapeutics share price today is $3.65 as on . Sonnet Biotherapeutics share today touched a day high of $3.87 and a low of $3.50.

What is the 52 week high and 52 week low for Sonnet Biotherapeutics share?

Sonnet Biotherapeutics share touched a 52 week high of $19.30 and a 52 week low of $1.08. Sonnet Biotherapeutics stock price today i.e. is trending at $3.65, lower by 81.09% versus the 52 week high.

How to invest in Sonnet Biotherapeutics Stock (SONN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sonnet Biotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sonnet Biotherapeutics Shares that will get you 0.4110 shares as per Sonnet Biotherapeutics share price of $3.65 per share as on August 26, 2025 at 12:40 AM IST.

What is the minimum amount required to buy Sonnet Biotherapeutics Stock (SONN) from India?

Indian investors can start investing in Sonnet Biotherapeutics (SONN) shares with as little as ₹87.537 or $1 (as of August 25, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.37 in Sonnet Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on August 25, 2025). Based on Sonnet Biotherapeutics share’s latest price of $3.65 as on August 26, 2025 at 12:40 AM IST, you will get 2.7397 shares of Sonnet Biotherapeutics. Learn more about fractional shares .

What are the returns that Sonnet Biotherapeutics has given to Indian investors in the last 5 years?

Sonnet Biotherapeutics stock has given -99.95% share price returns and 18.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?